Paper26207756
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
Hafiane A and 3 others. PLoS One, 2015. Cited by 48 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro. Papers, record 26207756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26207756
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter 1 | Major topic |
| Apolipoproteins E | Major topic |
| Cholesterol | Major topic |
| High-Density Lipoproteins, Pre-beta | Major topic |
| Peptides | Major topic |
| Animals | |
| Apolipoprotein A-I | |
| Biological Transport | |
| CD36 Antigens | |
| Cell Line | |
| Cell Line, Tumor | |
| Dose-Response Relationship, Drug | |
| Foam Cells | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| Macrophages | |
| Male | |
| Mice, Inbred C57BL | |
| Phospholipids | |
| Rats | |
| Time Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R33 CA094304 | NCI NIH HHS | United States | R33CA094304 | PubMed and NIH | NIH RePORTER |
| MOP 15042 | Canadian Institutes of Health Research | Canada | PubMed | PubMed |
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,680,471 | An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration. | Int J Biol Sci | 2009 | https://conductscience.org/library/papers/19680471 | PubMed |
| 2 | 24,569,554 | The structure/function of apoprotein A-I mimetic peptides: an update. | Curr Opin Endocrinol Diabetes Obes | 2014 | https://conductscience.org/library/papers/24569554 | PubMed |
| 3 | 23,781,332 | HDL, Atherosclerosis, and Emerging Therapies. | Cholesterol | 2013 | https://conductscience.org/library/papers/23781332 | PubMed |
| 4 | 18,939,908 | HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications. | Expert Rev Cardiovasc Ther | 2008 | https://conductscience.org/library/papers/18939908 | PubMed |
| 5 | 20,625,316 | Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells. | J Cardiovasc Pharmacol | 2010 | https://conductscience.org/library/papers/20625316 | PubMed |
| 6 | 7,794,908 | Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. | Biochemistry | 1995 | https://conductscience.org/library/papers/7794908 | PubMed |
| 7 | 4,179,999 | Practical methods for plasma lipoprotein analysis. | Adv Lipid Res | 1968 | https://conductscience.org/library/papers/4179999 | PubMed |
| 8 | 24,401,224 | CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. | Atherosclerosis | 2014 | https://conductscience.org/library/papers/24401224 | PubMed |
| 9 | 23,479,619 | ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23479619 | PubMed |
| 10 | 11,162,594 | Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11162594 | PubMed |
| 11 | 20,219,948 | Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. | Am J Physiol Cell Physiol | 2010 | https://conductscience.org/library/papers/20219948 | PubMed |
| 12 | 12,438,696 | Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12438696 | PubMed |
| 13 | 12,370,265 | Regulation and mechanisms of macrophage cholesterol efflux. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12370265 | PubMed |
| 14 | 6,404,278 | cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6404278 | PubMed |
| 15 | 1,637,786 | Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties. | Arterioscler Thromb | 1992 | https://conductscience.org/library/papers/1637786 | PubMed |
| 16 | 15,202,507 | Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells. | Acta Biochim Biophys Sin (Shanghai) | 2004 | https://conductscience.org/library/papers/15202507 | PubMed |
| 17 | 24,210,679 | High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes. | Am J Cardiol | 2014 | https://conductscience.org/library/papers/24210679 | PubMed |
| 18 | 14,660,648 | Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1). | J Biol Chem | 2004 | https://conductscience.org/library/papers/14660648 | PubMed |
| 19 | 19,839,639 | Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. | Biochemistry | 2009 | https://conductscience.org/library/papers/19839639 | PubMed |
| 20 | 21,476,522 | HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution. | Biochemistry | 2011 | https://conductscience.org/library/papers/21476522 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,906,332 | Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies. | Exp Neurobiol | 2026 | https://conductscience.org/library/papers/41906332 | PubMed |
| 41,750,400 | ABCA1: A Therapeutic Target for Improving Cholesterol Homeostasis in Peripheral Neuropathies. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750400 | PubMed |
| 40,211,340 | Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40211340 | PubMed |
| 38,102,668 | A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. | Alzheimers Res Ther | 2023 | https://conductscience.org/library/papers/38102668 | PubMed |
| 37,291,151 | Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. | Nat Commun | 2023 | https://conductscience.org/library/papers/37291151 | PubMed |
| 37,082,009 | Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages. | BBA Adv | 2021 | https://conductscience.org/library/papers/37082009 | PubMed |
| 36,979,840 | Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979840 | PubMed |
| 35,751,102 | Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35751102 | PubMed |
| 35,575,927 | HDL Mimetic Peptides. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/35575927 | PubMed |
| 35,530,134 | Remembering your A, B, C's: Alzheimer's disease and ABCA1. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35530134 | PubMed |
| 35,416,404 | The small HDL particle hypothesis of Alzheimer's disease. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/35416404 | PubMed |
| 35,087,605 | Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives. | Cardiovasc Ther | 2022 | https://conductscience.org/library/papers/35087605 | PubMed |
| 35,004,908 | New Strategies to Promote Macrophage Cholesterol Efflux. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/35004908 | PubMed |
| 34,977,908 | Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters. | Free Neuropathol | 2021 | https://conductscience.org/library/papers/34977908 | PubMed |
| 34,949,639 | Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34949639 | PubMed |
| 33,800,446 | Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases. | Cells | 2021 | https://conductscience.org/library/papers/33800446 | PubMed |
| 33,479,646 | Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators. | RSC Med Chem | 2020 | https://conductscience.org/library/papers/33479646 | PubMed |
| 32,899,606 | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease. | Biomolecules | 2020 | https://conductscience.org/library/papers/32899606 | PubMed |
| 32,290,082 | Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32290082 | PubMed |
| 32,087,290 | Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How. | Neurobiol Dis | 2020 | https://conductscience.org/library/papers/32087290 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26207756
GET https://conductscience.org/api/papers/v1/26207756/references?page=2